Daniel Levy

248.7k total citations · 65 hit papers
816 papers, 143.1k citations indexed

About

Daniel Levy is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Daniel Levy has authored 816 papers receiving a total of 143.1k indexed citations (citations by other indexed papers that have themselves been cited), including 430 papers in Cardiology and Cardiovascular Medicine, 142 papers in Molecular Biology and 91 papers in Genetics. Recurrent topics in Daniel Levy's work include Cardiovascular Function and Risk Factors (176 papers), Blood Pressure and Hypertension Studies (133 papers) and Cardiovascular Health and Disease Prevention (69 papers). Daniel Levy is often cited by papers focused on Cardiovascular Function and Risk Factors (176 papers), Blood Pressure and Hypertension Studies (133 papers) and Cardiovascular Health and Disease Prevention (69 papers). Daniel Levy collaborates with scholars based in United States, France and Canada. Daniel Levy's co-authors include Martin G. Larson, Emelia J. Benjamin, William B. Kannel, Ramachandran S. Vasan, Ralph B. D’Agostino, Peter W.F. Wilson, Jane C. Evans, Philip A. Wolf, Thomas J. Wang and Halit Silbershatz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Daniel Levy

806 papers receiving 138.0k citations

Hit Papers

Prediction of Coronary Heart Disease Using Risk Factor Ca... 1987 2026 2000 2013 1998 2013 1990 2013 1998 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prediction of Coronary Heart Disease Using Risk Factor Categories
    1998 7.2k citations Peter W.F. Wilson, Ralph B. D’Agostino et al. Circulation profile →
  2. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
    2013 5.5k citations Daniel Levy, Peter W.F. Wilson et al. Circulation profile →
  3. Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
    1990 4.5k citations Daniel Levy, William B. Kannel et al. profile →
  4. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
    2013 3.9k citations Ralph B. D’Agostino, Daniel Levy et al. profile →
  5. Impact of Atrial Fibrillation on the Risk of Death
    1998 3.5k citations Emelia J. Benjamin, Philip A. Wolf et al. Circulation profile →
  6. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
    2013 2.9k citations Daniel Levy, Peter W.F. Wilson et al. profile →
  7. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
    2013 2.7k citations Ralph B. D’Agostino, Daniel Levy et al. Circulation profile →
  8. Obesity and the Risk of Heart Failure
    2002 2.2k citations Satish Kenchaiah, Jane C. Evans et al. profile →
  9. The epidemiology of heart failure: The Framingham Study
    1993 1.7k citations William B. Kannel, Daniel Levy et al. profile →
  10. Arterial Stiffness and Cardiovascular Events
    2010 1.7k citations Gary F. Mitchell, Ramachandran S. Vasan et al. Circulation profile →
  11. Hemodynamic Patterns of Age-Related Changes in Blood Pressure
    1997 1.7k citations Martin G. Larson, William B. Kannel et al. Circulation profile →
  12. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
    2003 1.7k citations Daniel Levy et al. Circulation profile →
  13. Long-Term Trends in the Incidence of and Survival with Heart Failure
    2002 1.6k citations Daniel Levy, Satish Kenchaiah et al. profile →
  14. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.
    1998 1.5k citations William B. Kannel, Philip A. Wolf et al. The American Journal of Cardiology profile →
  15. The Progression From Hypertension to Congestive Heart Failure
    1996 1.5k citations Daniel Levy profile →
  16. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
    2001 1.5k citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  17. Lifetime Risk for Development of Atrial Fibrillation
    2004 1.5k citations Thomas J. Wang, Eric Leip et al. Circulation profile →
  18. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality
    2003 1.5k citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →
  19. Impact of Reduced Heart Rate Variability on Risk for Cardiac Events
    1996 1.4k citations Martin G. Larson, Jane C. Evans et al. Circulation profile →
  20. Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
    1993 1.4k citations Daniel Levy et al. Circulation profile →
  21. Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?
    1999 1.3k citations Martin G. Larson, Daniel Levy et al. Circulation profile →
  22. Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women
    2004 1.2k citations Gary F. Mitchell, Helen Parise et al. Hypertension profile →
  23. Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
    2004 1.2k citations Thomas J. Wang, Martin G. Larson et al. profile →
  24. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
    2015 1.1k citations Renate B. Schnabel, Xiaoyan Yin et al. profile →
  25. Lifetime Risk for Developing Congestive Heart Failure
    2002 1.1k citations Martin G. Larson, Eric Leip et al. Circulation profile →
  26. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
    1999 1.1k citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  27. Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
    1999 1.0k citations Martin G. Larson, William B. Kannel et al. profile →
  28. Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?
    2001 981 citations Martin G. Larson, Eric Leip et al. Circulation profile →
  29. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
    2013 979 citations Daniel Levy, Ramachandran S. Vasan et al. profile →
  30. Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
    2006 976 citations Thomas J. Wang, Philimon Gona et al. profile →
  31. Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men
    2002 960 citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  32. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age
    2006 901 citations Eric Leip, Martin G. Larson et al. Circulation profile →
  33. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)
    1999 890 citations Jane C. Evans, Daniel Levy et al. The American Journal of Cardiology profile →
  34. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
    2003 868 citations Daniel Levy et al. Circulation profile →
  35. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
    1994 852 citations Martin G. Larson, Emelia J. Benjamin et al. Circulation profile →
  36. Left Atrial Size and the Risk of Stroke and Death
    1995 839 citations Emelia J. Benjamin, Ralph B. D’Agostino et al. Circulation profile →
  37. Incidence and Prognosis of Syncope
    2002 815 citations Jane C. Evans, Martin G. Larson et al. profile →
  38. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension
    2012 781 citations Martin G. Larson, Joseph A. Vita et al. profile →
  39. Impact of Obesity on Plasma Natriuretic Peptide Levels
    2004 771 citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →
  40. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study
    2001 757 citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  41. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
    2009 754 citations Renate B. Schnabel, Daniel Levy et al. profile →
  42. Prevalence and Clinical Outcome of Mitral-Valve Prolapse
    1999 715 citations Daniel Levy, Martin G. Larson et al. profile →
  43. Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study
    1987 707 citations Daniel Levy, William B. Kannel et al. The American Journal of Cardiology profile →
  44. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
    1995 691 citations Ramachandran S. Vasan, Emelia J. Benjamin et al. profile →
  45. Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
    1988 667 citations Daniel Levy et al. profile →
  46. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
    1999 665 citations Martin G. Larson, Peter W.F. Wilson et al. profile →
  47. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death
    1998 617 citations Martin G. Larson, Emelia J. Benjamin et al. profile →
  48. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction
    2003 607 citations Ramachandran S. Vasan, Emelia J. Benjamin et al. Circulation profile →
  49. Risk factors for incident radiographic knee osteoarthritis in the elderly. The framingham study
    1997 598 citations David T. Felson, Daniel Levy et al. profile →
  50. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination
    2007 593 citations Qiong Yang, L. Adrienne Cupples et al. profile →
  51. A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community
    2003 586 citations Thomas J. Wang, Joseph M. Massaro et al. profile →
  52. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)
    1992 573 citations Martin G. Larson, Daniel Levy et al. The American Journal of Cardiology profile →
  53. Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort
    1989 571 citations Daniel Levy et al. profile →
  54. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals
    2005 558 citations Jane C. Evans, Thomas J. Wang et al. Circulation profile →
  55. The incidence and natural history of knee osteoarthritis in the elderly, the framingham osteoarthritis study
    1995 555 citations David T. Felson, Daniel Levy et al. profile →
  56. Atrial Fibrillation Begets Heart Failure and Vice Versa
    2016 550 citations Rajalakshmi Santhanakrishnan, Na Wang et al. Circulation profile →
  57. Rare independent mutations in renal salt handling genes contribute to blood pressure variation
    2008 543 citations Martin G. Larson, Christopher Newton‐Cheh et al. profile →
  58. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
    2008 542 citations Qiong Yang, Daniel Levy et al. profile →
  59. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study
    2008 522 citations Joseph M. Massaro, Daniel Levy et al. profile →
  60. Defining Diastolic Heart Failure
    2000 521 citations Ramachandran S. Vasan, Daniel Levy Circulation profile →
  61. Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged Adults
    2004 518 citations Ralph B. D’Agostino, Daniel Levy et al. profile →
  62. Circadian variation in the incidence of sudden cardiac death in the framingham heart study population
    1987 512 citations Daniel Levy, Geoffrey H. Tofler et al. The American Journal of Cardiology profile →
  63. Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction
    2009 512 citations Douglas S. Lee, Philimon Gona et al. Circulation profile →
  64. Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus
    2007 500 citations Caroline S. Fox, Ralph B. D’Agostino et al. Circulation profile →
  65. Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
    2012 391 citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Levy United States 171 90.7k 25.2k 19.4k 13.8k 13.8k 816 143.1k
Salim Yusuf Canada 181 103.5k 1.1× 28.9k 1.1× 24.4k 1.3× 10.7k 0.8× 15.1k 1.1× 1.3k 157.0k
William B. Kannel United States 158 71.4k 0.8× 22.9k 0.9× 25.8k 1.3× 10.7k 0.8× 15.0k 1.1× 477 128.7k
Ramachandran S. Vasan United States 146 57.4k 0.6× 13.8k 0.5× 16.0k 0.8× 7.7k 0.6× 15.2k 1.1× 955 108.8k
Peter W.F. Wilson United States 156 35.2k 0.4× 31.0k 1.2× 29.9k 1.5× 6.9k 0.5× 14.4k 1.0× 646 110.5k
John J.V. McMurray United Kingdom 161 87.0k 1.0× 22.7k 0.9× 30.4k 1.6× 7.1k 0.5× 8.6k 0.6× 1.5k 131.6k
Martin G. Larson United States 142 53.4k 0.6× 12.7k 0.5× 9.6k 0.5× 6.6k 0.5× 9.0k 0.7× 587 89.4k
Stuart Pocock United Kingdom 117 37.0k 0.4× 32.9k 1.3× 16.1k 0.8× 6.6k 0.5× 16.9k 1.2× 582 143.9k
Deepak L. Bhatt United States 142 57.5k 0.6× 40.1k 1.6× 23.5k 1.2× 7.9k 0.6× 14.2k 1.0× 2.0k 108.1k
Emelia J. Benjamin United States 141 70.6k 0.8× 11.9k 0.5× 8.4k 0.4× 9.6k 0.7× 12.3k 0.9× 788 102.0k
Gregg C. Fonarow United States 157 79.0k 0.9× 17.6k 0.7× 10.1k 0.5× 6.7k 0.5× 17.3k 1.3× 1.8k 113.5k

Countries citing papers authored by Daniel Levy

Since Specialization
Citations

This map shows the geographic impact of Daniel Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Levy more than expected).

Fields of papers citing papers by Daniel Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Levy. The network helps show where Daniel Levy may publish in the future.

Co-authorship network of co-authors of Daniel Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Levy. A scholar is included among the top collaborators of Daniel Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Levy. Daniel Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Courchesne, Paul, Martin G. Larson, Daniel Levy, et al.. (2024). Sex Differences in Protein Biomarkers and Measures of Fat Distribution. Journal of the American Heart Association. 13(22). e000223–e000223. 6 indexed citations
2.
Domingo‐Relloso, Arce, Roby Joehanes, Lies Lahousse, et al.. (2023). Smoking, blood DNA methylation sites and lung cancer risk. Environmental Pollution. 334. 122153–122153. 5 indexed citations
3.
Wang, Dongyu, Martin G. Larson, Emily S. Lau, et al.. (2023). Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease. Journal of the American Heart Association. 12(6). e027881–e027881. 8 indexed citations
4.
Ma, Jiantao, et al.. (2022). Blood transcriptomic biomarkers of alcohol consumption and cardiovascular disease risk factors: the Framingham Heart Study. Human Molecular Genetics. 32(4). 649–658. 3 indexed citations
5.
Bénétos, Athanase, Tsung-Po Lai, Simon Toupance, et al.. (2021). The Nexus Between Telomere Length and Lymphocyte Count in Seniors Hospitalized With COVID-19. The Journals of Gerontology Series A. 76(8). e97–e101. 26 indexed citations
6.
Santhanakrishnan, Rajalakshmi, Na Wang, Martin G. Larson, et al.. (2016). Atrial Fibrillation Begets Heart Failure and Vice Versa. Circulation. 133(5). 484–492. 550 indexed citations breakdown →
7.
Ho, Jennifer E., Wei Gao, Daniel Levy, et al.. (2016). Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities. American Journal of Respiratory and Critical Care Medicine. 194(1). 77–83. 63 indexed citations
8.
Lubitz, Steven A., Xiaoyan Yin, Michiel Rienstra, et al.. (2015). Long-Term Outcomes of Secondary Atrial Fibrillation in the Community. Circulation. 131(19). 1648–1655. 151 indexed citations
9.
Rienstra, Michiel, Susan Cheng, Martin G. Larson, et al.. (2011). Vitamin D status is not related to development of atrial fibrillation in the community. American Heart Journal. 162(3). 538–541. 54 indexed citations
10.
Lee, Douglas S., Joseph M. Massaro, Thomas J. Wang, et al.. (2007). Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life. Hypertension. 50(5). 869–876. 76 indexed citations
11.
Newton‐Cheh, Christopher, Chao‐Yu Guo, Martin G. Larson, et al.. (2007). Common Genetic Variation in KCNH2 Is Associated With QT Interval Duration. Circulation. 116(10). 1128–1136. 62 indexed citations
12.
Newton‐Cheh, Christopher, Chao‐Yu Guo, Philimon Gona, et al.. (2007). Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample. Hypertension. 49(4). 846–856. 163 indexed citations
13.
Kathiresan, Sekar, Philimon Gona, Martin G. Larson, et al.. (2006). Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function. Circulation. 113(7). 938–945. 71 indexed citations
14.
Mitchell, Gary F., Joseph A. Vita, Martin G. Larson, et al.. (2005). Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic Stiffness. Circulation. 112(24). 3722–3728. 236 indexed citations
15.
Fox, Caroline S., Qiong Yang, L. Adrienne Cupples, et al.. (2004). Genomewide Linkage Analysis to Serum Creatinine, GFR, and Creatinine Clearance in a Community-Based Population. Journal of the American Society of Nephrology. 15(9). 2457–2461. 112 indexed citations
16.
Gottlieb, Daniel J., J. B. Wilk, Jane C. Evans, et al.. (2001). Heritability of Longitudinal Change in Lung Function. American Journal of Respiratory and Critical Care Medicine. 164(9). 1655–1659. 50 indexed citations
17.
Mendes, Lisa A., Jane C. Evans, Daniel Levy, et al.. (2001). Echocardiographic Features of the Right Heart in Sleep-Disordered Breathing. American Journal of Respiratory and Critical Care Medicine. 164(6). 933–938. 96 indexed citations
18.
LaValley, Michael P., Stephen R. Evans, George O'connor, et al.. (1999). Evidence for decline in disability and improved health among persons aged 55 to 70 years: the Framingham Heart Study.. American Journal of Public Health. 89(11). 1678–1683. 61 indexed citations
19.
Givelber, Rachel J., et al.. (1998). Segregation Analysis of Pulmonary Function among Families in the Framingham Study. American Journal of Respiratory and Critical Care Medicine. 157(5). 1445–1451. 80 indexed citations
20.
Galderisi, Maurizio, Emelia J. Benjamin, Jane C. Evans, et al.. (1992). Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). The American Journal of Cardiology. 70(15). 1341–1346. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salim Yusuf Breakdown of academic impact, for papers by William B. Kannel Breakdown of academic impact, for papers by Ramachandran S. Vasan Breakdown of academic impact, for papers by Peter W.F. Wilson Breakdown of academic impact, for papers by John J.V. McMurray Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by Stuart Pocock Breakdown of academic impact, for papers by Deepak L. Bhatt Breakdown of academic impact, for papers by Emelia J. Benjamin Breakdown of academic impact, for papers by Gregg C. Fonarow
Rankless by CCL
2026